ELRIG Cell & Gene Therapy 2020
10 November - 11 November
The first ELRIG meeting on Advances in Cell and Gene Therapies will be held on the 10th and 11th of November 2020 at the AstraZeneca R&D site in Gothenburg. This interactive 2-day conference will host world-leading scientists from academia and industry to discuss current and future perspectives of Cell and Gene Therapies.
Cell and gene therapies are rapidly evolving at a fast pace, revealing many new and exciting therapeutic opportunities not previously amenable to drug discovery. We aim to bring together scientists from academia, pharma, biotech, and CRO’s to engage with speakers at the cutting edge of developing and applying cell and gene therapies.
The event will help participants develop a better understanding of the field and provide networking opportunities with a range of key experts. Our aim is to create an open and inspiring environment that will foster discussions and the identification of opportunities for collaboration with a scientific program developed around three key focus areas:
- Cell-based therapies across disease areas
- Advanced therapies in oncology
- Therapies for genetic conditions
There will be numerous opportunities to network with scientists and researchers from the pharmaceutical, academic and vendor communities throughout the 2-day conference. The program also includes poster viewing sessions, a poster snapshot presentation opportunity for select posters, vendor exhibition, speaker’s dinner and tour of the Amazing Journey at AstraZeneca.
Mogrify™ has developed a proprietary direct cellular conversion technology, which makes it possible to transform (transmogrify) any mature human cell type into any other without going through a pluripotent stem cell- or progenitor cell-state.